Literature DB >> 7726206

Is cholinergic sensitivity a genetic marker for the affective disorders?

D S Janowsky1, D H Overstreet, J I Nurnberger.   

Abstract

The recent literature on the involvement of cholinergic muscarinic mechanisms and adrenergic/cholinergic balance in affective disorders is reviewed and integrated with the older literature. There is strong evidence supporting the presence of exaggerated responses (behavioral, neuroendocrine, sleep) to cholinergic agents in affective disorder patients relative to normal controls and certain other psychiatric patients. There is also some, albeit less, conclusive evidence that these exaggerated responses may occur in euthymic individuals with a history of affective disorders, or in children at risk for development of affective disorders. Despite these promising results, suggesting a role for acetylcholine in the genetics of the affective disorders, further work in biochemistry and genetics is needed to link specific muscarinic receptors or other cholinergic variables to affective illness.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7726206     DOI: 10.1002/ajmg.1320540412

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  37 in total

Review 1.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

Review 2.  Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.

Authors:  Maura L Furey; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2013-08       Impact factor: 4.384

3.  Risk factors for tobacco dependence in adolescent smokers.

Authors:  I Karp; J O'Loughlin; J Hanley; R F Tyndale; G Paradis
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

4.  Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor.

Authors:  T Miyakawa; M Yamada; A Duttaroy; J Wess
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

5.  Neuropeptide expression in rats exposed to chronic mild stresses.

Authors:  Valeriy Sergeyev; Serguei Fetissov; Aleksander A Mathé; Patricia A Jimenez; Tamas Bartfai; Patrick Mortas; Laurent Gaudet; Jean-Luc Moreau; Tomas Hökfelt
Journal:  Psychopharmacology (Berl)       Date:  2004-10-30       Impact factor: 4.530

6.  Prenatal stress enhances stress- and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release in adult rats.

Authors:  J C Day; M Koehl; V Deroche; M Le Moal; S Maccari
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

7.  α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties.

Authors:  Yann S Mineur; Emily B Einstein; Patricia A Seymour; Jotham W Coe; Brian T O'neill; Hans Rollema; Marina R Picciotto
Journal:  Behav Pharmacol       Date:  2011-08       Impact factor: 2.293

Review 8.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

9.  Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours.

Authors:  Ekaterini Blaveri; Fiona Kelly; Alessandra Mallei; Kriss Harris; Adam Taylor; Juliet Reid; Maria Razzoli; Lucia Carboni; Chiara Piubelli; Laura Musazzi; Girogio Racagni; Aleksander Mathé; Maurizio Popoli; Enrico Domenici; Stewart Bates
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

10.  Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression.

Authors:  Clare J Wilhelm; Dongseok Choi; Marilyn Huckans; Laura Manthe; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2012-11-12       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.